Nurix Therapeutics, Inc. NRIX Amount that if recognized, would affect the effective tax rate or regulatory liability
Amount that if recognized, would affect the effective tax rate or regulatory liability at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate.
The official record: Nurix Therapeutics, Inc.’s 10-K, filed January 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s amount that if recognized, would affect the effective tax rate or regulatory liability.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s amount that if recognized, would affect the effective tax rate or regulatory liability?
- Nurix Therapeutics, Inc. (NRIX) reported amount that if recognized, would affect the effective tax rate or regulatory liability of $500K in Q3 2025.